Loading...

Guidelines for cellular and molecular pathology content in clinical trial protocols published

The SPIRIT-Path guidelines for the inclusion of pathology in clinical trial protocols have been published in The Lancet Oncology. Prof Anna DeFazio, Chair TR-ANZGOG Steering Committee The SPIRIT-Path extension guidelines were developed [...]

Guidelines for cellular and molecular pathology content in clinical trial protocols published2021-10-07T05:58:12+11:00

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations

STICs and STONEs is a randomised, Phase II, double-blind, placebo-controlled trial of aspirin in the prevention of ovarian cancer in women with BRCA1 and BRCA2 mutations. Prof Phillips, Principal Investigator of STICs and STONEs, [...]

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations2021-09-28T03:53:44+10:00

Honour Her live auction launch announcement features on ABC Breakfast News

Honour Her, a campaign led by ANZGOG's fundraising arm WomenCan, has been raising funds throughout September for ANZGOG’s gynaecological cancer research by showcasing the work of emerging artists in a virtual gallery. In addition to this, [...]

Honour Her live auction launch announcement features on ABC Breakfast News2021-09-28T03:37:18+10:00

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study

A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study2021-09-15T00:55:56+10:00
Go to Top